KRAS and cancer: Ferroptotic cancer cells release high mobility group box (HMBG), mutant KRAS oncoprotein or other damage-associated molecular patterns (DAMPs), leading to increased inflammatory responses in macrophages171 and the polarization of macrophages to the M2 phenotype, thereby supporting tumor growth172.